Research · 1 min read
AI Drug Discovery Is Moving Into the Clinic — Numbers Still Have to Be Checked Case by Case
Insilico, Recursion and XtalPi are putting model-found molecules into human trials; indication, phase and response rates have to come from each company's own disclosures.